Need for pharmacogenomic information also for generic medications: recommendation of the European Society of Pharmacogenomics and Theranostics (ESPT).
作者信息
Seist Gérard
机构信息
Cardiovascular Genetic Research Unit, University of Lorraine, Nancy, France.
出版信息
Drug Metabol Drug Interact. 2012;27(2):119. doi: 10.1515/dmdi-2012-0010.
PMID:22706235
Abstract
摘要
相似文献
1
Need for pharmacogenomic information also for generic medications: recommendation of the European Society of Pharmacogenomics and Theranostics (ESPT).仿制药也需要药物基因组学信息：欧洲药物基因组学与治疗诊断学学会（ESPT）的建议
Drug Metabol Drug Interact. 2012;27(2):119. doi: 10.1515/dmdi-2012-0010.
2
The pharmacogenomics of clopidogrel.氯吡格雷的药物基因组学
World Neurosurg. 2012 Mar-Apr;77(3-4):406-7. doi: 10.1016/j.wneu.2012.02.040. Epub 2012 Feb 11.
3
Current status of clopidogrel pharmacogenomics.氯吡格雷药物基因组学的现状
Pharmacogenomics. 2012 Nov;13(15):1671-4. doi: 10.2217/pgs.12.153.
4
Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin.药物遗传学检测：对氯吡格雷和华法林心血管治疗的影响
Cardiovasc Ther. 2010 Jun;28(3):135-8. doi: 10.1111/j.1755-5922.2010.00176.x.
5
The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects.CYP2C19的常见基因变异影响健康受试者中氯吡格雷活性代谢物的药代动力学和药效学。
J Thromb Haemost. 2008 Aug;6(8):1439-41. doi: 10.1111/j.1538-7836.2008.03050.x. Epub 2008 Jun 4.
6
Clopidogrel poor metabolizers may need alternative to standard regimen.
Am J Health Syst Pharm. 2010 May 15;67(10):779-80. doi: 10.2146/news100036.
7
Clopidogrel hyporesponsiveness and the FDA boxed warning: detection and management of patients with genetic polymorphisms.氯吡格雷低反应性与美国食品药品监督管理局黑框警告：基因多态性患者的检测与管理
Am J Health Syst Pharm. 2011 Mar 15;68(6):529-32. doi: 10.2146/ajhp100422.
8
ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association.美国心脏病学会基金会/美国心脏协会氯吡格雷临床警报：应对美国食品药品监督管理局“黑框警告”：美国心脏病学会基金会临床专家共识文件特别工作组和美国心脏协会的报告
Circulation. 2010 Aug 3;122(5):537-57. doi: 10.1161/CIR.0b013e3181ee08ed. Epub 2010 Jun 28.
9
Clopidogrel and the concept of high-risk pharmacokinetics.氯吡格雷与高风险药代动力学概念
Circulation. 2009 Apr 28;119(16):2127-30. doi: 10.1161/CIRCULATIONAHA.109.865907.
10
[Genetic variability in the efficacy of clopidogrel].[氯吡格雷疗效的基因变异性]
Ugeskr Laeger. 2013 Mar 11;175(11):729-32.
Zotero 插件